Effect of Prophylactic Ketorolac on CME After Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Macular Edema, Cystoid
Interventions
DRUG

ketorolac tromethamine 0.5% (Acular®)

Trial Locations (1)

K7L 5G2

Hotel Dieu Hospital, Kingston

All Listed Sponsors
lead

Queen's University

OTHER

NCT00335439 - Effect of Prophylactic Ketorolac on CME After Cataract Surgery | Biotech Hunter | Biotech Hunter